Search results
Found 30896 matches for
Patients set to benefit from new guidelines on Artificial Intelligence health solutions
10 September 2020
Patients could benefit from a faster and more effective introduction of artificial intelligence (AI) innovations to diagnose and treat disease – thanks to the first international standards for reporting of clinical trials for AI.
Workload linked with an increased risk of knee osteoarthritis
9 September 2020
Men and women working in heavy manual occupations are twice as likely to suffer from knee osteoarthritis (OA), the most common joint disorder, compared to those in sedentary occupations according to a new study published in the prestigious journal Seminars in Arthritis and Rheumatism.
Cancer care during COVID-19: lessons from The Oxford Bone Tumour and Soft Tissue Sarcoma service
26 August 2020
Sarcoma cancer in Oxford was reorganised during the pandemic. Two studies reveal their success and serve as a guide to other units facing the similar challenge of supporting patients.
Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin
24 August 2020
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.
Patient’s fundraising takes him to the top of Scafell Pike
20 August 2020
Hip replacement patient Nick Birch scales his second mountain to raise funds for University research
IL-22 pathway linked to poor prognosis in colon cancer
18 August 2020
Research shows how IL-22 interacts with KRAS mutant tumours to promote excessive growth in colorectal cancer
Pain trajectory defines knee osteoarthritis subgroups
13 August 2020
Researchers at NDORMS have identified four subgroups of knee osteoarthritis which will improve patient treatment and drug development.
CRAFFT trial opens to recruitment!
11 August 2020
The CRAFFT trial has now opened sites to recruitment.
Grant towards OHDSI Global Research on COVID-19 treatments
10 August 2020
An international cohort of OHDSI collaborators obtain a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network.
NDORMS joins collaboration to address COVID-19 in Europe
27 July 2020
The collaboration brings the European Health Data & Evidence Network (EHDEN) together with the European Medicines Agency and partners.
Six-month outcomes after treatment for COVID-19 on intensive care units in England
24 July 2020
Researchers at the University of Oxford are investigating the long-term health outcomes for patients who have been treated for severe COVID-19 disease in intensive care.
New Associate Professors and University Research Lecturers at NDORMS
23 July 2020
The University of Oxford has awarded the title of Associate Professor to seven senior researchers at NDORMS, and three University Research Lecturer titles.
Numerous jobs linked to increased risk of knee osteoarthritis
23 July 2020
Stay-at-home parents, cleaners, and blue-collar workers found to be more likely to develop osteoarthritis
Marie Curie Fellowship awarded to Mariana Borsa
10 July 2020
Congratulations to Mariana Borsa for being awarded the Marie Skłodowska-Curie Actions – Individual Fellowship
Reach for the sky
8 July 2020
A building project to extend the Kennedy Institute of Rheumatology building with a new floor will create much needed space for the Institute to expand, particularly in the areas of data science and clinical trials.
Kennedy Professor leads Cellular Life Theme of Reuben College
1 July 2020
Professor Mark Coles was recently appointed to the governing body of the University’s newest graduate college.
Joint cell discovery offers new hope for people with rheumatoid arthritis
29 June 2020
The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long- term remission.
Sir Marc Feldmann awarded the 2020 Tang Prize in Biopharmaceutical Science
22 June 2020
Recognised for the part he played in the discovery of anti-TNF therapy, Dr Feldmann is now exploring whether the antibody can be effective for COVID-19.
Patients with rheumatic pain increasingly turning to opioids
18 June 2020
Reporting at EULAR, researchers found that opioid use by patients with rheumatic and musculoskeletal pain was on the rise in Europe.